Drawing for HEALTH MINTS

USPTO serial 97727068

HEALTH MINTS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
YAO, GRETTA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HEALTH MINTS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Louis C. Paul

Louis C. Paul LOUIS C. PAUL & ASSOCIATES, PLLC250 PARK AVE7TH FLOORNEW YORK, NY 10177

Goods and services

ClassDescriptionStatusFirst use
030Non-medicated lozengesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 15, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 15, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 15, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 15, 2024EX2GSOU EXTENSION 2 GRANTED
Nov 15, 2024EXT2SOU EXTENSION 2 FILED
Nov 15, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 22, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 21, 2024EX1GSOU EXTENSION 1 GRANTED
May 21, 2024EXT1SOU EXTENSION 1 FILED
May 21, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 21, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 26, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 26, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 6, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 18, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 18, 2023XAECEXAMINER'S AMENDMENT ENTERED
Aug 18, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 18, 2023GNEAEXAMINERS AMENDMENT E-MAILED
Aug 18, 2023CNEAEXAMINERS AMENDMENT -WRITTEN
Aug 17, 2023DOCKASSIGNED TO EXAMINER
Jan 18, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 24, 2022NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance